Mankind Pharma Limited — Board Meeting, 06-11-2025: Outcome of Board Meeting
06-11-2025 | 09:33 pm
06-11-2025 | 09:33 pm
Mankind Pharma's Board approved Q2/H1 consolidated financial results. Revenue for the quarter stood at ₹3,697.16 Cr, with profit reaching ₹520.18 Cr. A strategic update noted the ₹797 Cr Women's Health Portfolio transfer to BSV became effective Nov 1.
No comments yet. Be the first to comment!
